Riskpilot← Back to searchSign inGet full accessUttran Psykiatri AB
ABActiveOrg 5569261042Bergtorpsvägen 3Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2025
SEK 954K
EBITDA margin
27.1%
+14515% vs 2024
Equity ratio
63.4%
Financial strength
Net profit 2025
SEK 196K
+15142% vs 2024
| Revenue | SEK 954K | — |
| EBITDA | SEK 259K | +14515% |
| Net profit | SEK 196K | +15142% |
| Total assets | SEK 387K | -58% |
| Equity | SEK 246K | -73% |
| Employees | 0 | — |
Legal name
Uttran Psykiatri AB
Org number
5569261042
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 mars 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva hälso- och sjukvård såsom psykologbedömning, neuropsykiatrisk utredning samt psykologisk behandling. Bolaget skall även bedriva bemannningsverksamhet inom hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Bergtorpsvägen 3
Email
robertkulhan@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 10 163 | 9 313 | 5 216 | 5 220 | 1 589 | −0 | 0 | 954 |
| Staff expenses | — | — | — | — | — | — | — | — | −1 | −0 | −227 |
| EBITDA | −28 | 399 | 24 | 470 | −473 | −780 | 4 498 | −454 | 3 | 2 | 259 |
| Depreciation & amort. | −311 | −286 | −294 | −164 | −169 | −175 | −97 | −0 | — | — | — |
| EBIT | −339 | 113 | −270 | 306 | −642 | −955 | 4 401 | −454 | 3 | 2 | 259 |
| Net financials | −21 | −24 | −23 | −32 | −34 | −14 | −154 | −13 | −8 | −0 | 0 |
| Profit before tax | −360 | 90 | −293 | 275 | −676 | −969 | 3 612 | −18 | −9 | 2 | 259 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −393 | −4 | −1 | −0 | −63 |
| Net profit | −360 | 90 | −293 | 275 | −676 | −969 | 3 219 | −22 | −10 | 1 | 196 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 215 | 1 662 | 1 786 | 1 412 | 1 329 | 1 179 | 3 678 | 1 552 | 933 | 930 | 387 |
| Equity | −693 | −604 | −896 | −622 | −1 298 | −2 266 | 953 | 931 | 922 | 923 | 246 |
| Long-term debt | 1 026 | 517 | 971 | 535 | 880 | 922 | 0 | 0 | — | — | — |
| Short-term debt | 1 882 | 1 749 | 1 711 | 1 499 | 1 746 | 2 523 | 2 090 | 436 | 11 | 7 | 142 |
| Total debt | 2 908 | 2 266 | 2 682 | 2 034 | 2 626 | 3 445 | 2 090 | 436 | 11 | 7 | 142 |
EBITDA margin
27.1%
This company
15.8%
Market median
+72% vs market
20152025
Equity ratio
63.4%
This company
38.2%
Market median
+66% vs market
20152025
Return on equity
79.6%
This company
18.4%
Market median
+333% vs market
20152025
Net profit margin
20.5%
This company
8.1%
Market median
+153% vs market
20152025
Asset turnover
2.46×
This company
1.12×
Market median
+120% vs market
20152025
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NK Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bashe Holding AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bashe Holding AB
Uttran Psykiatri AB Board members of Uttran Psykiatri AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niklas Kenneth Makal | Audit | 0 companies |
| Sabri Hanna | Deputy Board Member | 0 companies |
| Adnan Bashe | Deputy Board Member | 0 companies |
| Inez Lovisa Bengtsson | Deputy Board Member | 0 companies |
| Robert Kulhan | Board of Directors | 0 companies |
| Emanuel Josef Bashe | Board of Directors | 0 companies |
| Raphael Elia Kulhan | Deputy Board Member | 0 companies |